期刊论文详细信息
Chemistry Central Journal
Structures in solid state and solution of dimethoxy curcuminoids: regioselective bromination and chlorination
Petra Galer1  Amalija Golobič1  Jože Koller1  Berta Košmrlj1  Boris Šket1 
[1] Faculty of Chemistry and Chemical Technology, University of Ljubljana, Aškerčeva 5, SI-1000, Ljubljana, Slovenia
关键词: α-halodiketones;    Halogenation;    Enols;    Regioselectivity;    Theoretical investigations;    NMR experiments of solids;    X-ray structures;    Dimethoxy curcuminoids;   
Others  :  787886
DOI  :  10.1186/1752-153X-7-107
 received in 2013-01-08, accepted in 2013-06-06,  发布年份 2013
PDF
【 摘 要 】

Background

Several papers described the structure of curcumin and some other derivatives in solid and in solution. In the crystal structure of curcumin, the enol H atom is located symmetrically between both oxygen atoms of the enolone fragment with an O···O distance of 2.455 Å, which is characteristic for symmetrical H-bonds. In the solution, the geometry of the enolone fragment is attributed to the inherent disorder of the local environment, which solvates one of the basic sites better than the other, stabilizing one tautomer over the other. In this paper, how the position of methoxy groups in dimethoxy curcuminoids influence the conformation of molecules and how the halogen atoms change it when they are bonded at α-position in keto-enol part of molecules is described.

Results

Six isomers of dimethoxy curcuminoids were prepared. Conformations in solid state, which were determined by X-ray single crystallography and 1H MAS and 13C CPMAS NMR measurements, depend on the position of methoxy groups in curcuminoid molecules. In solution, a fast equilibrium between both keto-enol forms exists. A theoretical calculation finding shows that the position of methoxy groups changes the energy of HOMO and LUMO. An efficient protocol for the highly regioselective bromination and chlorination leading to α-halogenated product has been developed. All α-halogenated compounds are present mainly in cis keto-enol form.

Conclusions

The structures in solid state of dimethoxy curcuminoids depend on the position of methoxy groups. The NMR data of crystalline solid samples of 3,4-diOCH3 derivative, XRD measurements and X-ray structures lead us to the conclusion that polymorphism exists in solids. The same conclusion can be done for 3,5-diOCH3 derivative. In solution, dimethoxy curcuminoids are present in the forms that can be described as the coexistence of two equivalent tautomers being in fast equilibrium. The position of methoxy groups has a small influence on the enolic hydrogen bond. Theoretical calculations show that the energy gap between HOMO and LUMO depend on the position of methoxy groups and are lower in solution. Chlorination and bromination on α-position of 1,3-diketone moiety do not change the preferential form being cis keto-enol as in parent compounds.

【 授权许可】

   
2013 Galer et al.; licensee Chemistry Central Ltd.

【 预 览 】
附件列表
Files Size Format View
20140702211758521.pdf 2115KB PDF download
Figure 15. 77KB Image download
Figure 5. 28KB Image download
Figure 13. 65KB Image download
Figure 12. 81KB Image download
Figure 11. 40KB Image download
Figure 10. 46KB Image download
Figure 9. 49KB Image download
Figure 8. 56KB Image download
Figure 7. 32KB Image download
Figure 6. 18KB Image download
Figure 5. 144KB Image download
Figure 4. 94KB Image download
Figure 3. 40KB Image download
Figure 2. 77KB Image download
Figure 1. 66KB Image download
Scheme 1 31KB Image download
【 图 表 】

Scheme 1

Figure 1.

Figure 2.

Figure 3.

Figure 4.

Figure 5.

Figure 6.

Figure 7.

Figure 8.

Figure 9.

Figure 10.

Figure 11.

Figure 12.

Figure 13.

Figure 5.

Figure 15.

【 参考文献 】
  • [1]Aggarwal BB, Sundaram C, Malani N, Ichikawa H: Curcumin: the Indian solid gold. Adv Exp Med Biol 2007, 595:1-75.
  • [2]Srimal RC, Dhawan BN: Pharmacology of Diferuloyl Methane (Curcumin), a Non-Steroidal Anti-Inflammatory Agent. J Pharm Pharmacol 1973, 25:447-452.
  • [3]Sharma OP: Antioxidant Activity of Curcumin and Related Compounds. Biochem Pharmacol 1976, 25:1811-1812.
  • [4]Singh S, Aggarwal BB: Activation of Transcription Factor NF-κB is Suppressed by Curcumin (Diferulolylmethane). J Biol Chem 1995, 270:24995-25000.
  • [5]Goel A, Kannumakkara AB, Aggarwal BB: Curcumin as “Curecumin”: From Kitchen to Clinic. Biochem Pharmacol 2008, 75:787-809.
  • [6]Lantz RC, Chen GJ, Solyom AM, Jolad SD, Timmermann BN: The Effect of Turmeric Extracts on Inflammatory Mediator Production. Phytomed 2005, 12:445-452.
  • [7]Yang F, Lim GP, Begum AN, Ubeda OJ, Simmons MR, Ambegaokar SS, Chen P, Kayed R, Glabe CG, Frautschy SA, Cole GM: Curcumin Inhibits Formation of Amyloid β Oligomers and Fibrils, Binds Plaques, and Reduces Amyloid in Vivo. J Biol Chem 2005, 280:5892-5901.
  • [8]Ryu EK, Choe YS, Lee K-H, Choi Y, Kim B-T: Curcumin and Dehydrozingerone Derivatives: Synthesis, Radiolabeling, and Evaluation for β-Amyloid Plaque Imaging. J Med Chem 2006, 49:6111-6119.
  • [9]Leu T-H, Maa M-C: The Molecular Mechanisms for the Antitumorigenic Effect of Curcumin. Curr Med Chem-Anti-Cancer Agents 2002, 2:357-370.
  • [10]Moos PJ, Edes K, Mullally JE, Fitzpatrick FA: Curcumin Impairs Tumor Suppressor p53 Function in Colon Cancer Cells. Carcinog 2004, 25:1611-1617.
  • [11]Fujisawa S, Atsumi T, Ishihara M, Kadoma Y: Cytotoxicity, ROS-Generation Activity and Radical-Scavenging Activity of Curcumin and Related Compounds. Anticancer Res 2004, 24:563-569.
  • [12]Aggarwal BB, Kumar A, Bharti AC: Anticancer Potential of Curcumin: Preclinical and Clinical Studies. Anticancer Res 2003, 23:363-398.
  • [13]Tønnesen HH, Karlsen J, Mostad A: Structural Studies of Curcuminoids I. The Crystal Structure of Curcumin. Acta Chem Scand B 1982, 36:475-479.
  • [14]Parimita SP, Ramshankar YV, Suresh S, Row TNG: Redetermination of Curcumin: (1E,4Z,6E)-5-Hydroxy-1,7-Bis(4-Hydroxy-3-Methoxyphenyl)hepta-1,4,6-Trien-3-One. Acta Cryst. E 2007, 63:o860-o862.
  • [15]Mague JT, Alworth WL, Payton FL: Curcumin and Derivatives. Acta Cryst. C 2004, 60:o608-o610.
  • [16]Sanphui P, Goud NR, Khandavilli UBR, Bhanoth S, Nangia A: New polymorphs of curcumin. Chem Commun 2011, 47:5013-5015.
  • [17]Balasubramanian K: Molecular Orbital Basis for Yellow Curry Spice Curcumin’s Prevention of Alzheimer’s Disease. J Agric Food Chem 2006, 54:3512-3520.
  • [18]Cornago P, Claramunt RM, Bouissane L, Alkorta I, Elguero J: A Study of the Tautomerism of β-Dicarbonyl Compounds with Special Emphasis on Curcuminoids. Tetrahedron 2008, 64:8089-8094.
  • [19]Payton F, Sandusky P, Alworth WL: NMR Study of the Solution Structure of Curcumin. J Nat Prod 2007, 70:143-146.
  • [20]Nardo L, Andreoni A, Tønnesen HH: Intramolecular H-Bond Formation Mediated De-Excitation of Curcuminoids: a Time-Resolved Fluorescence Study. 2011, 353-375. [In Hydrogen Bonding and Transfer in the Excited State. Volume I&II]
  • [21]Nardo L, Andreoni A, Masson M, Haukvik T, Tønnesen HH: Studies on Curcumin and Curcuminoids. XXXIX. Photophysical Properties of Bisdemethoxycurcumin. J Fluoresc 2011, 21:627-635.
  • [22]Nardo L, Andreoni A, Bondani M, Masson M, Haukvik T, Tønnesen HH: Studies on Curcumin and Curcuminoids. XLVI. Photophysical Properties of Dimethoxycurcumin and Bis-dehydroxycurcumin. J Fluoresc 2012, 22:597-608.
  • [23]Agrawal DK, Mishra PK: Curcumin and Its Analogues: Potential AnticancerAgents. Med Res Rev 2010, 30:818-860.
  • [24]Pedersen U, Rasmussen PB, Lawesson S-O: Synthesis of Naturally Occurring Curcuminoids and Related Compounds. Liebigs Ann. Chem 1985, 8:1557-1569.
  • [25]Shen L, Ji H-F: Theoretical Study on Physicochemical Properties of Curcumin. Spectrochim. Acta, Part A 2007, 67:619-623.
  • [26]Ghosh R, Mondal JA, Palit DK: Ultrafast Dynamics of the Excited States of Curcumin in Solution. J Phys Chem B 2010, 114:12129-12143.
  • [27]Neumann CS, Fujimori DG, Walsh CT: Halogenation Strategies in Natural Product Biosynthesis. Chem Biol 2008, 15:99-109.
  • [28]Jamode VS, Babrekar SA: Synthesis of Propan-1,3-Diones and Chromens. Asian J Chem 2009, 21:3553-3556.
  • [29]Lee K-H, Lin L, Shih CC-Y, Su C-Y, Ishida J, Ohtsu H, Wang H-K, Itokawa H, Chang C: Novel Curcumin Analogues and uses thereof. WO 2006., 2006044379(A2)
  • [30]Lin L, Shi Q, Nyarko AK, Bastow KF, Wu C-C, Su C-Y, Shih CC-Y, Lee K-H: Antitumor Agents. 250. Design and Synthesis of New Curcumin Analogues as Potential Anti-Prostate Cancer Agents. J Med Chem 2006, 49:3963-3972.
  • [31]Lin L, Shi Q, Su C-Y, Shih CC-Y, Lee K-H: Antitumor Agents 247. New 4-Ethoxycarbonylethyl Curcumin Analogs as Potential Antiandrogenic Agents. Bioorg Med Chem 2006, 14:2527-2534.
  • [32]see De Kimpe N, Verhé R, For a monograph: The Chemistry of α-Haloketones, α-Haloaldehydes, and α-Haloimines. New York: Wiley; 1988.
  • [33]Larock RC: Comprehensive Organic Transformation. 2nd edition. New York: VCH Publishers Inc; 1999:717-718.
  • [34]Khan AT, Ali MA, Goswami P, Choudhury LH: A Mild and Regioselective Method for α-Bromination of β-Keto Esters and 1,3-Diketones Using Bromodimethylsulfonium Bromide (BDMS). J Org Chem 2006, 71:8961-8963.
  • [35]Pravst I, Zupan M, Stavber S: Solvent-Free Bromination of 1,3-Diketones and β-Keto Esters with NBS. Green Chem 2006, 8:1001-1005.
  • [36]Alinezhad H, Tajbakhsh M, Tehrani SS: Selective Monobromination of 1,3-Diones with N-Bromosaccharin/Mg(ClO4)2 System in Solution and under Solvent-Free Conditions. Bull. Korean Chem Soc 2011, 32:1543-1546.
  • [37]Galer P, Kosmrlj B, Sket B: Highly Regioselective Halogenation of 1-Phenyl-3-(3,5-Dimethoxyphenyl)-Propane-1,3-Dione. Tetrahedron 2011, 67:2103-2109.
  • [38]Weber WM, Hunsaker LA, Abcouwer SF, Deck LM, Jagt DLV: Anti-Oxidant Activities of Curcumin and Related Enones. Bioorg Med Chem 2005, 13:3811-3820.
  • [39]Takahashi T, Hijikuro I, Sugimoto H, Kihara T, Shimmyo Y, Niidome T: Novel Curcumin Derivative. WO 2008., 2008066151(A1)
  • [40]Amolins MW, Peterson LB, Blagg BSJ: Synthesis and Evaluation of Electron-Rich Curcumin Analogues. Bioorg Med Chem 2009, 17:360-367.
  • [41]Nurfina AN, Reksohadiprodjo MS, Timmerman H, Jenie UA, Sugiyanto D, van der Goot H: Synthesis of some Symmetrical Curcumin Derivatives and their Antiinflammatory Activity. Eur J Med Chem 1997, 32:321-328.
  • [42]Hahm E-R, Cheon G, Lee J, Kim B, Park C, Yang C-H: New and Known Symmetrical Curcumin Derivatives Inhibit the Formation of Fos-Jun-DNA Complex. Cancer Lett 2002, 184:89-96.
  • [43]Gilli G, Gilli P: The Nature of the Hydrogen Bond. Outline of a Comprehensive Hydrogen Bond Theory. Oxford: Oxford University Press; 2009.
  • [44]Perrin CL: Symmetry of Hydrogen Bonds in Solution. Pure Appl Chem 2009, 81:571-583.
  • [45]Perrin CL: Are Short, Low-Barrier Hydrogen Bonds Unusually Strong? Acc Chem Res 2010, 43:1550-1557.
  文献评价指标  
  下载次数:176次 浏览次数:27次